Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Cerrato · SciRah

Researcher profile · Semantic Scholar

C. Cerrato

Share profile

C. Cerrato — researcher profile on SciRah

h-index: 12
Works: 29
Citations: 1,493

Most-cited papers

Autologous transplantation and maintenance therapy in multiple myeloma.
A. Palumbo, F. Cavallo, F. Gay, F. Di Raimondo +23 more
2014New England Journal of Medicine746 citations Open access
Semantic Scholar
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials
S. Bringhen, M. Mateos, S. Zweegman, A. Larocca +24 more
2013Haematologica213 citations Open access
Semantic Scholar
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma.
A. Palumbo, F. Gay, F. Cavallo, F. Di Raimondo +24 more
2015Journal of Clinical Oncology145 citations Open access
Semantic Scholar
Efficacy of carfilzomib lenalidomide dexamethasone (KRd) with or without transplantation in newly diagnosed myeloma according to risk status: Results from the FORTE trial.
F. Gay, C. Cerrato, M. Petrucci, R. Zambello +14 more
2019Journal of Clinical Oncology79 citations
Semantic Scholar
Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)
F. Gay, C. Cerrato, D. Rota-Scalabrini, M. Galli +23 more
2018Blood47 citations Open access
Semantic Scholar
Plasma cell leukemia: update on biology and therapy
Roberto Mina, M. D'Agostino, C. Cerrato, F. Gay +1 more
2017Leukemia and Lymphoma45 citations Open access
Semantic Scholar
CD38 as an immunotherapeutic target in multiple myeloma
F. Bonello, M. D'Agostino, Maria Moscvin, C. Cerrato +2 more
2018Expert Opinion on Biological Therapy37 citations Open access
Semantic Scholar
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case‐matched study
F. Morabito, S. Bringhen, A. Larocca, P. Wijermans +30 more
2014American journal of hematology/oncology23 citations Open access
Semantic Scholar
Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients
A. Palumbo, S. Bringhen, O. Villani, A. Siniscalchi +6 more
201223 citations
Semantic Scholar
Diagnosis and therapy of multiple myeloma
A. Palumbo, C. Cerrato
2013The Korean Journal of Internal Medicine20 citations Open access
Semantic Scholar
The mechanism of action, pharmacokinetics, and clinical efficacy of carfilzomib for the treatment of multiple myeloma
Chiara Pautasso, S. Bringhen, C. Cerrato, V. Magarotto +1 more
2013Expert Opinion on Drug Metabolism & Toxicology19 citations
Semantic Scholar
New pharmacotherapy options for multiple myeloma
Roberto Mina, C. Cerrato, A. Bernardini, Elena Aghemo +1 more
2016Expert Opinion on Pharmacotherapy17 citations
Semantic Scholar
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response
Roberto Mina, M. Petrucci, P. Corradini, S. Spada +21 more
2018Clinical Lymphoma, Myeloma & Leukemia12 citations Open access
Semantic Scholar
A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma
C. Cerrato, M. Petrucci, M. Genuardi, F. Gentilini +15 more
201312 citations
Semantic Scholar
Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma
S. Bringhen, F. Gay, Chiara Pautasso, C. Cerrato +2 more
2012Expert Opinion on Drug Metabolism & Toxicology11 citations
Semantic Scholar
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis
C. Cerrato, F. Di Raimondo, L. De Paoli, S. Spada +27 more
2018Journal of Cancer Research and Clinical Oncology9 citations Open access
Semantic Scholar
Optimal management of elderly patients with myeloma
C. Cerrato, Roberto Mina, A. Palumbo
2014Expert Review of Anticancer Therapy8 citations Open access
Semantic Scholar
Role of consolidation/maintenance therapy in multiple myeloma.
A. Palumbo, Roberto Mina, C. Cerrato, F. Cavallo
2013Clinical Lymphoma, Myeloma & Leukemia7 citations Open access
Semantic Scholar
Initial treatment of nontransplant patients with multiple myeloma.
C. Cerrato, A. Palumbo
2013Seminars in Oncology6 citations Open access
Semantic Scholar
S872 CARFILZOMIB LENALIDOMIDE DEXAMETHASONE (KRD) WITH OR WITHOUT TRANSPLANTATION IN NEWLY DIAGNOSED MYELOMA (FORTE TRIAL): EFFICACY ACCORDING TO RISK STATUS
F. Gay, C. Cerrato, Rota D. Scalabrini, A. Belotti +23 more
2019HemaSphere5 citations Open access
Semantic Scholar
Impact of Autologous Transplantation Vs. Chemotherapy Plus Lenalidomide in Newly Diagnosed Myeloma According to Patient Prognosis: Results of a Pooled Analysis of 2 Phase III Trials
C. Cerrato, R. Hájek, F. Di Raimondo, T. Caravita +21 more
20145 citations
Semantic Scholar
Updated efficacy data and MRD analysis according to risk status in newly diagnosed myeloma patients treated with carfilzomib + lenalidomide or cyclophosphamide (FORTE trial).
R. Foà, P. Musto, C. Cerrato, B. Gamberi +15 more
20182 citations
Semantic Scholar
Continuous treatment improves survival of newly diagnosed multiple myeloma patients achieving complete response: data from 5 phase III trials including young and elderly patients
C. Cerrato, M. Petrucci, M. Pellegrino, G. Gaidano +21 more
20151 citations Open access
Semantic Scholar
Impact of Complete Response on Survival with Either Autologous Stem Cell Transplantation or Conventional Chemotherapy: Results of a Pooled Analysis of 5 Phase III Trials in Newly Diagnosed Multiple Myeloma Patients
Roberto Mina, A. Larocca, M. Offidani, S. Bringhen +23 more
20151 citations
Semantic Scholar
Prognostic Implication of Somatic Mutations by Next Generation Sequencing: an Analysis from the MMRF CoMMpass Study in Newly Diagnosed Multiple Myeloma Patients
M. D'Agostino, S. Oliva, A. Larocca, S. Spada +19 more
20160 citations
Semantic Scholar
Impact of complete response on progression-free survival and overall survival in newly diagnosed myeloma patients treated with autologous stem cell transplantation or conventional chemotherapy: results of a pooled analysis of 5 phase III trials
Roberto Mina, A. Larocca, M. Offidani, V. Magarotto +21 more
20150 citations
Semantic Scholar
Significant Survival Improvement with Maintenance in Patients Achieving a Complete Response: Pooled Analysis of 4 Italian Phase III Trials in Newly Diagnosed Multiple Myeloma Patients
C. Cerrato, M. Petrucci, P. Musto, G. Gaidano +18 more
20150 citations
Semantic Scholar
Ruolo del trapianto e del mantenimento nel trattamento del mieloma multiplo nell’era dei nuovi farmaci
C. Cerrato, A. Palumbo
20140 citations
Semantic Scholar
Treatment Intensi ﬁ cation With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response
Roberto Mina, Maria Teresa Petrucci, P. Corradini, S. Spada +21 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Palumbo×26
Invite
A. Palumbo — researcher profile on SciRah
M. Boccadoro×19
Invite
M. Boccadoro — researcher profile on SciRah
M. Offidani×13
Invite
M. Offidani — researcher profile on SciRah
Roberto Mina×12
Invite
Roberto Mina — researcher profile on SciRah

×11

Invite

P. Musto — researcher profile on SciRah

F. Patriarca×10

Invite

F. Patriarca — researcher profile on SciRah

Invite

M. Petrucci — researcher profile on SciRah

F. Di Raimondo×8

Invite

F. Di Raimondo — researcher profile on SciRah

Invite

T. Caravita — researcher profile on SciRah

Invite

M. Cavo — researcher profile on SciRah

Invite

S. Bringhen — researcher profile on SciRah

P. Corradini×7

Invite

P. Corradini — researcher profile on SciRah